课题基金 / 基金详情

BAL AND SERUM MARKERS FOR DISEASE ACTIVITY IN SARCOIDOSIS

BAL AND SERUM MARKERS FOR DISEASE ACTIVITY IN SARCOIDOSIS
结节病疾病活动的 BAL 和血清标志物
批准号:
3943185
负责人:
DIANNE Y BELL
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

DIANNE Y BELL的其他基金

相似基金

相关文献

中文摘要
翻译
这项正在进行的研究的目标是找出 患者灌洗液和血清与 肺结节病的疾病活动性,可用于 预测未经治疗的患者的病程并监测对 在接受治疗的病人中进行治疗。这件事会做到的 在两个方面。首先,选定的变量,以BALF和 血清,将与临床病程相匹配的患者接受 在两次评估之间的一段时间内没有皮质类固醇。 其次,无论是接受治疗的患者还是未经治疗的患者,都将通过 重复支气管肺泡灌洗(3-5BAL,6mo)。间隔)到 确定哪些变量在以下患者中恢复正常 显示临床改善,并保持或变得异常 病情恶化或未能好转的患者。推定标记物 将被评估的疾病活动性包括细胞变量 (总数、种类、亚群、活力)和可溶性蛋白质 成分(免疫球蛋白、急性期反应物、介体)。 细胞类型和亚群将使用单克隆进行鉴定 表面标志物的抗体。蛋白质将通过以下方式测量 针对单特异性抗体的径向免疫扩散。 中介物将在成纤维细胞增殖的生物测定中定量。 我们的目的是确定两个非常具体的标记 间质性肺病的肺泡期和纤维期,以及 分离出那些化学和细胞变化,这些变化 与那些与修复相关的人的伤害有关。这个 人口统计因素在决定自然因素中的作用 该病的病史将在 北卡罗来纳州和佛蒙特州的患者团体。
英文摘要
It is the objective of this ongoing study to identify variables in patient lavage fluid (BALF) and serum which are correlated with disease activity in pulmonary sarcoidosis, which can be used to predict course in the untreated patient and monitor response to therapy in the patient who receives treatment. This will be done in two ways. First, selected variables, measured in BALF and in serum, will be matched with clinical course in patients receiving no corticosteroids during an interval between evaluations. Second, patients, both treated and untreated, will be studied by repeat bronchoalveolar lavage (3-5 BAL, at 6 mo. intervals) to determine which variables return to normal in those patients who show clinical improvement, and which remain or become abnormal in patients who deteriorate or fail to improve. Putative markers of disease activity which will be evaluated include cell variables (total numbers, kinds, subsets, viability) and soluble protein components (immunoglobulins, acute phase reactants, mediators). Cell types and subsets will be identified using monoclonal antibodies for surface markers. Proteins will be measured by radial immunodiffusion against monospecific antibodies. Mediators will quantitated in bioassay for fibroblast proliferation. Our purpose is to identify very specific markers for both the alveolitic and fibrotic phases of interstitial lung disease, and to separate out those chemical and cellular changes which are associated with injury from those associated with repair. The contribution of demographic factors in determining the natural history of the disease will be evaluated within and between the North Carolina and Vermont patient groups.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BRONCHOALVEOLAR LAVAGE IN INTERSTITIAL LUNG DISEASE
  • 批准号:
    3882574
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    DIANNE Y BELL
  • 依托单位:
BAL AND SERUM MARKERS FOR ACTIVITY IN SARCOIDOSIS
IMMUNE MECHANISM IN HUMAN ASBESTOS
BAL AND SERUM MARKERS FOR ACTIVITY IN SARCOIDOSIS
海外基金